Tyco Seeking Respiratory, Anesthesiology Lines In Wake Of USSC Purchase
This article was originally published in The Gray Sheet
After moving to shore up its operating room product lines with the pending acquisition of U.S. Surgical, Tyco International is looking to expand its respiratory and anesthesiology offerings.
You may also be interested in...
Tyco International's decision to account for its $4.2 bil. stock acquisition of Mallinckrodt as a purchase rather than a pooling-of-interests transaction, gives the company the flexibility to divest Mallinckrodt's imaging drugs and bulk pharmaceuticals businesses and concentrate on the fast-growing respiratory products division.
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.